News | Leads Implantable Devices | February 17, 2016

FDA Approves St. Jude Medical’s MultiPoint Pacing Technology

Technology provides another option for non-responders to cardiac resynchronization therapy

St. Jude Medical, FDA clearance, MultiPoint Pacing technology, CRT-D, CRT-P

February 17, 2016 — St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval of the first-to-market MultiPoint Pacing technology featured on the Quadra line of cardiac resynchronization therapy defibrillators (CRT-D) and pacemakers. Specific models include the Quadra Assura MP CRT-D, the Quadra Allure MP CRT-pacemaker (CRT-P) and two new quadripolar Quartet LV leads.

MultiPoint Pacing technology provides additional options which may benefit CRT patients who are not responsive to other pacing alternatives. This approval is the first step in the rollout of MultiPoint Pacing technology, and availability to U.S. physicians is expected in the first half of this year.

Approximately 23 million people worldwide are afflicted with congestive heart failure and 2 million new cases are diagnosed worldwide each year. Studies have shown that CRT can improve the quality of life for many patients with heart failure, a progressive condition in which the heart weakens and loses its ability to pump an adequate supply of blood. CRT resynchronizes the lower chambers (ventricles) of the heart by sending uniquely programmed electrical impulses to stimulate each ventricle to beat in sync for optimal cardiac performance.

Despite the improvements seen with quadripolar CRT technology, non-responders to therapy remain a significant issue. Also, non-responders to CRT are not able to be identified at the time of implant and individual patient response can be unpredictable.

Previous studies have shown that activating more ventricular tissue faster may enhance heart muscle performance. MultiPoint Pacing technology allows physicians the opportunity to capture more left ventricular tissue quickly by delivering pacing pulses to multiple left ventricle locations rather than the traditional single pulse for each heartbeat. Using the Quartet LV lead with its four uniquely spaced electrodes, physicians now have the capability to program two pulses from a single lead and tailor them to the specific needs of each patient.

“Having the ability to truly individualize cardiac resynchronization therapy is a significant step forward in the clinical approach to treating some of our most complex heart failure patients,” said Gery Tomassoni, M.D., director of electrophysiology at Baptist Health Lexington in Lexington, Ky. “MultiPoint Pacing technology provides a new set of tools that can be non-invasively programmed in an attempt to improve CRT response, thus opening up an important new treatment option for many patients who may need it.”

St. Jude Medical also announced FDA approval of additional quadripolar pacing Quartet LV leads, which can be used with MultiPoint Pacing technology, as well as the programmer-based Auto VectSelect Quartet Test. The two new leads are designed based on the company’s clinically proven Quadripolar LV lead technology and include additional electrode spacing options on two new S-curve shaped lead designs. The expanded family of Quartet LV leads offers more options to effectively meet the needs of patients with larger as well as smaller cardiac anatomies. Physicians can quickly customize therapy using the new automated Auto VectSelect Quartet Test, which is designed to offer comprehensive testing results so appropriate therapy options can be easily and efficiently programmed for each patient in a streamlined workflow.

For more information: www.sjm.com

Related Content

A step-by-step overview of how to perform interventional CRT (I-CRT) lead placement using the coronary sinus. This image shows the Medtronic Attain Performa quadripolar lead and VivaQuad XT CRT-D system.
Feature | EP Lab | January 21, 2019 | Matthew S. McKillop, M.D., FACC, FHRS, and Seth J. Worley, M.D.
Interventional...
An implanted ICD showing its three venous leads. These multiple CRT leads can cause issues when they need to be replaced and are abandoned with new leads put over them in the SVC, which may require lead extraction.

An implanted ICD showing its three leads in the venous system. 

Feature | EP Lab | January 13, 2019 | Dave Fornell, Editor
To extract or abandon broken or infected implantable, venous...
Videos | EP Lab | January 03, 2019
This is a quick video tour of one of the dedicated...
HHS and NASA Team Up to Explore Health on Earth and in Outer Space

Image courtesy of NASA

News | EP Lab | December 14, 2018
The Department of Health and Human Services (HHS) recently entered into an interagency agreement with the National...
Technology Improvements Driving Electrophysiology Market Growth

Navik 3D Cardiac Mapping System image courtesy of APN Health.

News | EP Lab | December 10, 2018
December 10, 2018 — Electrophysiology, whil
Vagal Maneuvers With Supraventricular Tachycardia

Image courtesy of ACLS Certification Institute

Feature | EP Lab | December 05, 2018
Supraventricular tachycardia (SVT) is a common heart abnormality that presents as a fast heart rate. SVT is a generic...
Societies Publish New Guidance for Treatment of Slow, Irregular Heartbeats
News | EP Lab | November 09, 2018
The American College of Cardiology (ACC), the American Heart Association (AHA) and the Heart Rhythm Society (HRS)...
A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.

A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.

News | EP Lab | June 05, 2018
June 5, 2018 — Philips Healthcare has signed an agreement to acquire EPD Solutions, a provider of image-guidance in c
A recent study shows the Baylis NRG radiofrequency (RF) Transseptal puncture catheter has a lower incidence of embolism in EP cases.
News | EP Lab | May 21, 2018
May 21, 2018 — A recent study published in Heart and Vessels has found that the use of the Baylis Medical NR
Overlay Init